AMYLOID A AMYLOIDOSIS AND RENAL FAILURE IN A COURSE OF CASTLEMAN DISEASE
ANTONI SYDOR,
ANTONI SYDOR
Internal Disease, Nephrology and Dialysis Center of the St. Lukas Voivodship Hospital in Tarnow, Tarnow,
Search for more papers by this author MARLENA MADURA,
MARLENA MADURA
Internal Disease, Nephrology and Dialysis Center of the St. Lukas Voivodship Hospital in Tarnow, Tarnow,
Search for more papers by this author MAŁGORZATA WAGROWSKA-DANILEWICZ,
MAŁGORZATA WAGROWSKA-DANILEWICZ
Division of Nephropathology, Medical University in Lodz, and
Search for more papers by this author JACEK NOWAK,
JACEK NOWAK
Internal Disease, Nephrology and Dialysis Center of the St. Lukas Voivodship Hospital in Tarnow, Tarnow,
Search for more papers by this author MICHAŁ NOWICKI,
MICHAŁ NOWICKI
Department of Nephrology, Hypertension and Kidney Transplantation, Medical University of Lodz, Lodz, Poland
Search for more papers by this author
ANTONI SYDOR,
ANTONI SYDOR
Internal Disease, Nephrology and Dialysis Center of the St. Lukas Voivodship Hospital in Tarnow, Tarnow,
Search for more papers by this author MARLENA MADURA,
MARLENA MADURA
Internal Disease, Nephrology and Dialysis Center of the St. Lukas Voivodship Hospital in Tarnow, Tarnow,
Search for more papers by this author MAŁGORZATA WAGROWSKA-DANILEWICZ,
MAŁGORZATA WAGROWSKA-DANILEWICZ
Division of Nephropathology, Medical University in Lodz, and
Search for more papers by this author JACEK NOWAK,
JACEK NOWAK
Internal Disease, Nephrology and Dialysis Center of the St. Lukas Voivodship Hospital in Tarnow, Tarnow,
Search for more papers by this author MICHAŁ NOWICKI,
MICHAŁ NOWICKI
Department of Nephrology, Hypertension and Kidney Transplantation, Medical University of Lodz, Lodz, Poland
Search for more papers by this author
First published: 09 November 2007
No abstract is available for this article.
REFERENCES
- 1
Frizzera G,
Peterson BA,
Bayrd ED,
Goldman A.
A systemic lymphoproliferative disorder with morphological features of Castleman disease: Clinical findings and clinicopathological correlation in 15 patients.
J. Clin. Oncol.
1985; 3: 1202–16.
- 2
Montoli A,
Minola E,
Stabile F et al.
End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman disease).
Am. J. Nephrol.
1995; 15: 142–6.
- 3
Tanaka K,
Horita M,
Shibayama H et al.
Secondary amyloidosis associated with Castleman disease.
Intern. Med.
1995; 34: 122–6.
- 4
Altiparmak MR,
Pamuk GE,
Pamuk ON,
Dogusoy G.
Secondary amyloidosis in Castleman disease: Review of the literature and report of a case.
Ann. Hematol.
2002; 81: 366–9.
- 5
Falck HM,
Maury CPJ,
Teppo AM,
Wegelius O.
Persistently high serum amyloid A protein and C-reactive protein levels correlate with rapid progression of secondary amyloidosis.
BMJ
1983; 286: 1391.
- 6
Lui SL,
Chan KW,
Li FK,
Cheng IKP,
Chan TM.
Castleman's disease and mesangial proliferative glomerulonephritis: The role of interleukin-6.
Nephron
1998; 78: 323–7.
- 7
West KP,
Morgan DR,
Launder I.
Angiofollicular lymph node hyperplasia with amyloidosis.
Postgrad. Med. J.
1989; 65: 108–11.
- 8
Yoshizaki K,
Matsuda T,
Nishimoto T et al.
Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman disease.
Blood
1989; 74: 1360–67.
